• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Stigma of Substance Use Disorder Varies by Condition, Provider

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 30, 2025.

WEDNESDAY, July 30, 2025 -- Health care provider stigma toward substance use disorder (SUD) varies by condition and provider, according to a study published online July 23 in Addiction.

Carrigan L. Parish, Ph.D., from the Columbia Mailman School of Public Health in New York City, and colleagues quantified the prevalence and intensity of provider stigma toward patients with SUD by substance use type and compared with other conditions using a national probability sample survey, conducted from October 2020 to October 2022. Data were obtained from 1,240 randomly selected primary care physicians (PCPs) and emergency medicine physicians (EMPs) and dentists.

The researchers found the lowest stigma rating for diabetes and the highest for stimulant use disorders (mean, 23.2 and 36.3, respectively). Significantly higher stigma was seen toward opioid use disorder versus alcohol use disorder (effect size, 0.49), while stigma toward stimulant use disorders was significantly higher than toward opioid use disorder (effect size, 0.11). Significantly higher stigma scores were seen for EMPs than PCPs, while stigma scores were significantly higher for PCPs than dentists. There was an association for lower stigma scores with provision of SUD referrals (effect size, −0.37), providing medications (effect sizes, −0.44, −1.26, and −0.73 for alcohol, opioid, and stimulant use disorder, respectively), and having available SUD consultation (effect sizes, −0.48, −0.51, and −0.59 for alcohol, opioid, and stimulant use disorders, respectively).

"Our findings show that many providers still feel uncomfortable treating patients with substance use disorders and that hesitancy leads directly to missed opportunities for care," Parish said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2025

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.